Sustainability at Roche
Our approach
For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage in the communities we work in and with.
Severin Schwan on sustainability
Severin Schwan, CEO of the Roche Group, on sustainability. "Developing medicines and tests is our main contribution to society."
Balance life
Roche commits to flexibility at the workplace and empowers people to deliver meaningful outcomes with balance.
The Roche story
The story of Roche underscores our longstanding commitment to creating a partnership between business and science that improves people’s lives.
Our impact on society
Innovating for patients
Providing a great workplace
Being a trustworthy partner
Environment and communities
Delivering continuous growth
Innovating for patients
63 million patients
treated with Roche medicines
>21 billion tests
conducted with Roche Diagnostics products
32 Roche medicines
listed on the WHO Model List of Essential Medicines
Providing a great workplace
68% employee engagement rate
32% of women
in key leadership positions
24% of key leaders
with diverse work experience
Being a trustworthy partner
50 new partnerships
in Diagnostics in 2019
78 new partnerships
in Pharmaceuticals in 2019
0
supplier with critical issue or discontinued based on audit results
Environment and communities
23.5% decrease
in water consumption since 2015
12% decrease
in energy consumption since 2015
29% improvement
in the eco-balance since 2014
Delivering continuous growth
+9% in Group sales
+11% in core operating profit
19% of sales invested in R&D
Explore our stories
External recognition
Our sustainability efforts have been recognised by key ratings such as Dow Jones Sustainability Indices (DJSI) or the Access to Medicine Index (AtMI).
Roche has been again recognised as one of the most sustainable healthcare companies in the Pharmaceutical Group of the Dow Jones Sustainability Indices 2019. This great result is based on an independent analysis of our economic, social and environmental performance.
